MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

504929

Report Date :

21.04.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

NAARI PHARMA PRIVATE LIMITED

 

 

Formerly known as :

INDO PHYTO CHEMICALS PRIVATE LIMITED

 

 

Registered Office :

C-3/199, Janakpuri, New Delhi-110058

Mobile No.:

91-7830203003 [Mr. Sarabjeet]

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

23.02.1978

 

 

Com. Reg. No.:

55-008881

 

 

Capital Investment / Paid-up Capital :

INR 5.104 Million

 

 

CIN No.:

[Company Identification No.]

U74899DL1978PTC008881

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACI2995R

 

 

TIN No.:

07096947676

 

 

GSTN :

[Goods & Service Tax Registration No.]

07AAACI2995R2ZS

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in Manufacturing of Bulk Drugs, subject Manufactures Various Fermentation Intermediates, Active Pharma Ingredients (API's) and Finished Dosage Forms. [Registered Activity]

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 194900

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of “Sequent Scientific Limited” incorporated in the year 1978 having satisfactory track record.

 

The subject is engaged in manufacturing of active pharmaceutical ingredients (API), fermentation intermediaries and Finished Dosage Forms (FDF) products.

 

For the financial year 2017, the company has achieved decent growth in its revenue as compared to its previous year but has incurred loss during the year.

 

Rating takes into consideration, the satisfactory financial risk profile marked by adequate net worth base and strong debt protection metrics.

 

Rating continues to derive strength from its long and established track record of its business operation backed by corporate guarantee provided by its holding entity towards its borrowings.

 

However, these rating strengths are partially offset by exposure to intense completion in the international generics market, and growing regulatory scrutiny in emerging market, along with growing competition, substantial investment in infrastructure and R&D which impact in  profitability pressure among the major players.

 

Payment seems to be slow but correct.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Fund Based [Issuer Not Cooperating] = BBB+

Rating Explanation

Moderate degree of safety and moderate credit risk

Date

30.03.2018

 

Rating Agency Name

ICRA

Rating

Non-Fund Based = A2+

Rating Explanation

Strong Degree of safety and low credit risk.

Date

30.03.2018

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 21.04.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Sarabjeet

Designation :

Accounts Department

Contact No.:

91-7830203003

Date :

19.04.2018

 

 

LOCATIONS

 

Registered Office :

C-3/199, Janakpuri, New Delhi-110058, India

Tel. No.:

91-11-46474747

Mobile No.:

91-7830203003 [Mr. Sarabjeet]

Fax No.:

91-11-46474700

E-Mail :

info@indophytochemicals.com

sudhir.y@naari.co

Website :

http://www.indophytochemicals.com

 

 

Factory 1 :

Village Sakhanpur, PO Pirumadara, Tehsil-Ramnagar District- Nainital-244715, Uttarakhand, India

 

 

Factory 2:

Pirumdara, (Via Kashipur), District Nainital - 244713, Uttarakhand, India

 

 

Corporate Office :

210-A, Shahpur Jat, New Delhi - 110049, India

 

 

DIRECTORS

 

AS ON: 31.03.2017

 

Name :

Mr. Prithipal Singh Kochhar

Designation :

Wholetime Director

Address :

124, Sunder Nagar, 2nd Floor, New Delhi-110003, India

Date of Birth/Age :

26.03.1979

Qualification :

Graduate

Date of Appointment :

15.04.2015

DIN No.:

01052194

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U55100DL2007PTC163234

KILA TATARPUR HOTELS PRIVATE LIMITED

31/07/2008

U55101DL1998PTC092506

ARESKO ESTATES PRIVATE LIMITED

15/06/2007

U55101DL2006PTC148035

RAIPUR LODGE PRIVATE LIMITED

15/06/2007

U55101DL2006PTC148037

BAGRI FORT RESORTS PRIVATE LIMITED

15/06/2007

U55101DL2009PTC195516

MAHAR PALACE HOTEL & SPA PRIVATE LIMITED

26/10/2009

U74899DL1994PLC057954

ARESKO FINANCIAL SERVICES LIMITED

18/09/2009

U74899DL1995PTC067643

SUVINYS DEVELOPERS PRIVATE LIMITED

13/01/2007

U74999DL2005PTC138964

COMET CONVERSION SERVICES (INDIA) PRIVATE LIMITED

22/07/2005

 

 

Name :

Mr. Jagtaran Singh Kochhar

Designation :

Director

Address :

C-3/199, Janakpuri, New Delhi-110058, India

Date of Appointment :

17.04.2010

DIN No.:

03036555

 

 

Name :

Mr. Kannan Pudhucode Radhakrishnan

Designation :

Director

Address :

Flat D- 801, Chartered Beverly Hills, Gubblala Village, Subramanyapura, Bengaluru-560061, Karnataka, India

Date of Appointment :

27.01.2016

DIN No.:

03435209

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24230KA2007PTC042337

TENSHI KAIZEN PRIVATE LIMITED

28/04/2017

U32201KA2007PTC044638

QUADGEN WIRELESS SOLUTIONS PRIVATE LIMITED

01/03/2018

U70102MH2011PTC224475

SANTO PROPERTIES PRIVATE LIMITED

29/09/2012

U72200KA2016PTC093729

QUADGEN NETWORKS PRIVATE LIMITED

01/03/2018

U72400KL2002PTC015452

TRINITY MOBILITY PRIVATE LIMITED

27/11/2015

U74120MH2013PTC239820

ANTFARM BUSINESS INCUBATOR PRIVATE LIMITED

31/07/2017

U74140DL2006PTC146649

PATSYS CONSULTING PRIVATE LIMITED

30/09/2016

U74140KA2007PTC043095

STELIS BIOPHARMA PRIVATE LIMITED

08/08/2017

U74999KA2016PTC095360

TENSHI LIFE SCIENCES PRIVATE LIMITED

11/02/2017

 

 

KEY EXECUTIVES

 

Name :

Mr. Sarabjeet

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON: 31.03.2017

 

Names of Shareholders

No. of Shares

 

Percentage of Holding

Rajpal Singh Kochhar

250000

48.98

Sequent Scientific Limited, India

260400

51.02

 

 

 

Total

 

510400

100.00

 

 

AS ON: 19.09.2017

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters – Body Corporate

100.00

 

 

Total

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in Manufacturing of Bulk Drugs, subject Manufactures Various Fermentation Intermediates, Active Pharma Ingredients (API's) and Finished Dosage Forms. [Registered Activity]

 

 

Products :

ITC Code No.

 

Product Descriptions

24230000

Manufacturing of Bulk Drugs

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

PRODUCTION STATUS: NOT AVAILABLE

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

·         Kotak Mahindra Bank Limited

·         RBL Bank Limited

 

 

Facilities :

SECURED LOANS

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

66.313

34.181

 

 

 

Total

 

66.313

34.181

 

 

 

Auditors :

 

Name :

D D Bansal and Associates

Chartered Accountants

Address :

M -304 Dharama Apartments, Plot No 2, Indraprastha, Extension, Delhi 110092, India

PAN No.:

AACFD2943B

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding company :

Sequent Scientific Limited [L99999MH1985PLC036685]

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

·         Rakshit Organisational Operations And Transformations Private Limited [U74140DL2003PTC123410]

·         IK Enterprises

·         Aresko Restaurants Private Limited [U55101DL2000PTC105564]

·         Naari AG, Switzerland

 

 

 

CAPITAL STRUCTURE

 

AS ON: 31.03.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2500000

Equity Shares

INR 10/- each

INR 25.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

510400

Equity Shares

INR 10/- each

INR 5.104 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

31.03.2014

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

5.104

5.104

5.104

(b) Reserves & Surplus

63.125

116.086

97.748

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

68.229

121.190

102.852

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

204.289

138.828

0.000

(b) Deferred tax liabilities (Net)

16.302

0.000

0.000

(c) Other long term liabilities

0.000

0.000

2.372

(d) long-term provisions

4.371

2.486

0.000

Total Non-current Liabilities (3)

224.962

141.314

2.372

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

39.380

22.111

101.906

(b) Trade payables

265.922

332.933

241.434

(c) Other current liabilities

62.046

38.798

9.297

(d) Short-term provisions

0.000

0.000

0.000

Total Current Liabilities (4)

367.348

393.842

352.637

 

 

 

 

TOTAL

660.539

656.346

457.861

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

275.432

183.850

179.221

(ii) Intangible Assets

4.809

10.973

14.400

(iii) Capital work-in-progress

28.904

60.762

40.963

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.585

1.034

(d)  Long-term Loan and Advances

4.962

5.297

1.521

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

314.107

261.467

237.139

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

146.571

270.551

151.730

(c) Trade receivables

160.777

111.296

53.867

(d) Cash and cash equivalents

7.284

9.600

12.962

(e) Short-term loans and advances

31.800

3.078

1.809

(f) Other current assets

0.000

0.354

0.354

Total Current Assets

346.432

394.879

220.722

 

 

 

 

TOTAL

660.539

656.346

457.861

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

 

Revenue from Operations

908.961

674.772

358.157

 

 

Other Income

12.384

(0.329)

4.040

 

 

TOTAL                                    

921.345

674.443

362.197

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

523.457

507.241

261.815

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

98.372

(99.301)

(8.543)

 

 

Employees benefits expense

92.563

63.112

45.716

 

 

Other expenses

243.968

145.104

26.627

 

 

 

(53.991)

0.000

0.000

 

 

TOTAL                                    

904.369

616.156

325.615

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

16.976

58.287

36.582

 

 

 

 

 

Less

FINANCIAL EXPENSES                       

21.195

8.536

3.894

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION              

(4.219)

49.751

32.688

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

31.854

28.559

28.908

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX                        

(36.073)

21.192

3.780

 

 

 

 

 

Less

TAX                                                                 

16.888

2.855

0.559

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX               

(52.961)

18.337

3.221

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

545.490

414.550

86.187

 

TOTAL EARNINGS

545.490

414.550

86.187

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

241.298

369.174

NA

 

TOTAL IMPORTS

241.298

369.174

NA

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

(111.02)

35.93

6.31

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Cash generated from operations

NA

NA

NA

 

 

 

 

Net cash flows from (used in) operations

35.380

26.859

NA

 

 

 

 

Net cash flows from (used in) operating activities

19.078

24.005

NA

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

(Sundry Debtors / Income * 365 Days)

64.56

60.20

54.90

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

5.65

6.06

6.65

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

185.42

239.57

336.59

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.12

0.22

0.24

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.05

0.23

0.16

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.87

0.81

0.77

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

3.57

1.33

0.99

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

5.38

3.25

3.43

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

4.53

2.11

2.28

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

0.80

6.83

9.39

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Net Profit Margin

((PAT / Sales) * 100)

%

(5.83)

2.72

0.90

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

(8.02)

2.79

0.70

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

(77.62)

15.13

3.13

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

0.94

1.00

0.63

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.54

0.32

0.20

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.10

0.18

0.22

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

47.74

31.53

19.97

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

0.94

1.00

0.63

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts


 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particulars

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Share Capital

5.104

5.104

5.104

Reserves & Surplus

97.748

116.086

63.125

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

102.852

121.190

68.229

 

 

 

 

Long-term borrowings

0.000

138.828

204.289

Short term borrowings

101.906

22.111

39.380

Total borrowings

101.906

160.939

243.669

Debt/Equity ratio

0.991

1.328

3.571

 

 


 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Sales

358.157

674.772

908.961

 

 

88.401

34.706

 

 


 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Sales

358.157

674.772

908.961

Profit/ (Loss)

3.221

18.337

-52.961

 

0.90%

2.72%

-5.83%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 


 

INDEX OF CHARGES

 

CHARGES REGISTERED

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

G51793321

100028182

RBL BANK LIMITED

17/04/2016

09/08/2017

-

1178000000.0

631, 3RD BLOCK, 3RD CROSS, 100 FEET ROAD,NR. BDA COMPLEX, KORAMANGALABENGALURUUR244715IN

2

G12446274

10517012

KOTAK MAHINDRA BANK LIMITED

17/06/2014

23/09/2015

19/09/2016

181200000.0

E-220, EAST OF KAILASHNEW DELHIDL110065IN

3

C34127258

90038906

CENTRAL BANK OF INDIA

02/04/2004

20/09/2007

21/11/2014

10000000.0

RAMNAGAR ROADKASHIPURUR244713IN

4

C34583823

90031634

BANK OF BARODA

09/04/1979

-

14/11/2014

375000.0

KASHIPURNAINITALUPIN

 

 

UNSECURED LOANS

 

PARTICULARS 

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

LONG-TERM BORROWINGS

 

 

Other loans and advances, others

137.976

104.647

 

 

 

SHORT TERM BORROWINGS

 

 

Working capital loans from banks

39.380

22.211

 

 

 

Total

 

177.356

126.858

 

 

CHANGE OF ADDRESS:

 

The Registered address of the company has been shifted from 124, Sunder Nagar, New Delhi-110003, India to the present address w.e.f 25.04.2011

 

 

CORPORATE INFORMATION

 

Indo Phyto Chemicals Private Limited (‘The Company’) was incorporated on February 23, 1978. The Company has become subsidiary of the Public listed Company Sequent Scientific Limited (SSL) w.e.f January 27, 2016. SSL acquired the Holding equity from the erstwhile holding company i.e., Naari AG which is incorporated in Switzerland. The company is engaged in manufacturing of bulk drugs with the plant located at Kashipur, Uttarakhand. The company manufactures various Fermentation Intermediates, Active Pharma Ingredients (API's) and Finished Dosage Forms.

 


BUSINESS PERFORMANCE REVIEW

 

During the financial year 2015-16, the Company's total revenues stood at INR 908.960 Million as against INR 674.770 Million in 2014-15. The Company registered a net loss INR 52.960 Million.

 

 

FIXED ASSETS:

 

·         Land

·         Buildings

·         Plant and equipment

·         Furniture and fixtures

·         Vehicles

·         Computer equipments

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 66.02

UK Pound

1

INR 92.73

Euro

1

INR 81.46

 

 

INFORMATION DETAILS

 

Information Gathered by :

AKS

 

 

Analysis Done by :

NSG

 

 

Report Prepared by :

RUP

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.